PT - JOURNAL ARTICLE AU - Ray, Animesh AU - Singh, Komal AU - Mehdi, Farha AU - Chattopadhyay, Souvick AU - Jadon, Ranveer Singh AU - Nischal, Neeraj AU - Soneja, Manish AU - Sethi, Prayas AU - Meena, Ved Prakash AU - Trikha, Anjan AU - Batra, Gaurav AU - Wig, Naveet TI - Seroprevalence of anti-SARS-CoV-2 IgG antibodies in admitted patients at a tertiary referral centre in North India AID - 10.1101/2022.08.19.22278876 DP - 2022 Jan 01 TA - medRxiv PG - 2022.08.19.22278876 4099 - http://medrxiv.org/content/early/2022/08/22/2022.08.19.22278876.short 4100 - http://medrxiv.org/content/early/2022/08/22/2022.08.19.22278876.full AB - Background Seroprevalence of IgG antibodies against SARS-CoV-2 is an important tool to estimate true burden of infection in a given population. Serosurveys, though being conducted in different parts of India, are not readily published in entirety and often do not report on the different characteristics of the population studied. In this present study, we aimed to serially estimate the seroprevalence of anti-SARS-CoV-2 IgG antibody over 11 months at one of the largest government hospital in India.Method In this cross-sectional study which was conducted between between 9th June 2020 and 27th April 2021, consecutive patients admitted to medicine wards or intensive care units, who were negative for SARS-CoV-2 by RT-PCR or CBNAAT were included. The 2linic-demographic features of the subjects were recorded in pre-formed questionnaires. Anti-SARS-CoV2 antibody levels targeting recombinant spike receptor-binding domain (RBD) protein of SARS CoV-2 were estimated in serum sample by the ELISA method.Results A total of 916 patients were recruited over 11 months with mean age(±SD) 39.79±14.9 of years and 55% of population being males. In total 264(28.8%) patients were found to be seropositive. Residency in Delhi and non-smoking status conferred a higher risk for seropositivity. The adjusted odds ratio for seropositivity with regards to no smoking and residence out of Delhi were .31±.09 (Odds ratio ± S.E) and .65 ± .1 (Odds ratio ± S.E) respectively. No other factors like age, socio-economic status, contact history etc showed significant relationship with seropositivity.Conclusion The seropositivity rate among hospitalized patients was found to increase with time (from 8.45% to 38%) over a period of 9 months. Residence in Delhi and non-smokers had higher risk for seropositivity on multivariate analysis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAIIMS, Intramural Research GrantAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institute Ethics committee, AIIMS, New Delhi, Ref. No. IEC-547/19.06.2020, RP-15/2020I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data may be made available on request to the authors